Logo image of SYENS.BR

SYENSQO SA (SYENS.BR) Stock Fundamental Analysis

EBR:SYENS - Euronext Brussels - BE0974464977 - Common Stock - Currency: EUR

71.15  -1.37 (-1.89%)

Fundamental Rating

4

Taking everything into account, SYENS scores 4 out of 10 in our fundamental rating. SYENS was compared to 61 industry peers in the Chemicals industry. SYENS has an average financial health and profitability rating. SYENS is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

SYENS had negative earnings in the past year.
SYENS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: SYENS reported negative net income in multiple years.
In the past 5 years SYENS always reported a positive cash flow from operatings.
SYENS.BR Yearly Net Income VS EBIT VS OCF VS FCFSYENS.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

1.2 Ratios

SYENS's Return On Assets of -0.04% is in line compared to the rest of the industry. SYENS outperforms 46.03% of its industry peers.
Looking at the Return On Equity, with a value of -0.07%, SYENS is in line with its industry, outperforming 46.03% of the companies in the same industry.
With a decent Return On Invested Capital value of 3.24%, SYENS is doing good in the industry, outperforming 60.32% of the companies in the same industry.
SYENS had an Average Return On Invested Capital over the past 3 years of 8.10%. This is in line with the industry average of 6.72%.
The last Return On Invested Capital (3.24%) for SYENS is well below the 3 year average (8.10%), which needs to be investigated, but indicates that SYENS had better years and this may not be a problem.
Industry RankSector Rank
ROA -0.04%
ROE -0.07%
ROIC 3.24%
ROA(3y)2.81%
ROA(5y)0.13%
ROE(3y)7.26%
ROE(5y)-1.97%
ROIC(3y)8.1%
ROIC(5y)7.41%
SYENS.BR Yearly ROA, ROE, ROICSYENS.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

Looking at the Operating Margin, with a value of 6.59%, SYENS is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
In the last couple of years the Operating Margin of SYENS has declined.
With a Gross Margin value of 32.42%, SYENS perfoms like the industry average, outperforming 52.38% of the companies in the same industry.
SYENS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.59%
PM (TTM) N/A
GM 32.42%
OM growth 3Y-11.73%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.24%
GM growth 5YN/A
SYENS.BR Yearly Profit, Operating, Gross MarginsSYENS.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 10 -10 20 -20 30

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SYENS is still creating some value.
The number of shares outstanding for SYENS has been reduced compared to 1 year ago.
SYENS has a better debt/assets ratio than last year.
SYENS.BR Yearly Shares OutstandingSYENS.BR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
SYENS.BR Yearly Total Debt VS Total AssetsSYENS.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

SYENS has an Altman-Z score of 2.26. This is not the best score and indicates that SYENS is in the grey zone with still only limited risk for bankruptcy at the moment.
SYENS has a Altman-Z score (2.26) which is comparable to the rest of the industry.
The Debt to FCF ratio of SYENS is 9.75, which is on the high side as it means it would take SYENS, 9.75 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 9.75, SYENS is in the better half of the industry, outperforming 60.32% of the companies in the same industry.
SYENS has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
SYENS's Debt to Equity ratio of 0.25 is fine compared to the rest of the industry. SYENS outperforms 69.84% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 9.75
Altman-Z 2.26
ROIC/WACC0.47
WACC6.83%
SYENS.BR Yearly LT Debt VS Equity VS FCFSYENS.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

SYENS has a Current Ratio of 1.71. This is a normal value and indicates that SYENS is financially healthy and should not expect problems in meeting its short term obligations.
SYENS has a Current ratio (1.71) which is comparable to the rest of the industry.
SYENS has a Quick Ratio of 1.05. This is a normal value and indicates that SYENS is financially healthy and should not expect problems in meeting its short term obligations.
SYENS's Quick ratio of 1.05 is in line compared to the rest of the industry. SYENS outperforms 52.38% of its industry peers.
Industry RankSector Rank
Current Ratio 1.71
Quick Ratio 1.05
SYENS.BR Yearly Current Assets VS Current LiabilitesSYENS.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

3

3. Growth

3.1 Past

The earnings per share for SYENS have decreased strongly by -102.63% in the last year.
SYENS shows a decrease in Revenue. In the last year, the revenue decreased by -3.10%.
The Revenue has been growing slightly by 4.31% on average over the past years.
EPS 1Y (TTM)-102.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-26.54%
Revenue 1Y (TTM)-3.1%
Revenue growth 3Y4.31%
Revenue growth 5YN/A
Sales Q2Q%-49.24%

3.2 Future

Based on estimates for the next years, SYENS will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.44% on average per year.
Based on estimates for the next years, SYENS will show a small growth in Revenue. The Revenue will grow by 4.25% on average per year.
EPS Next Y20.04%
EPS Next 2Y18.78%
EPS Next 3Y20.29%
EPS Next 5Y9.44%
Revenue Next Year3.91%
Revenue Next 2Y4.78%
Revenue Next 3Y5.23%
Revenue Next 5Y4.25%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
SYENS.BR Yearly Revenue VS EstimatesSYENS.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B
SYENS.BR Yearly EPS VS EstimatesSYENS.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2 4 6 8

5

4. Valuation

4.1 Price/Earnings Ratio

SYENS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 11.07, the valuation of SYENS can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SYENS indicates a rather cheap valuation: SYENS is cheaper than 85.71% of the companies listed in the same industry.
SYENS is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 11.07
SYENS.BR Price Earnings VS Forward Price EarningsSYENS.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400 -600 -800 -1K

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SYENS is valued a bit cheaper than 76.19% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SYENS is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 34.44
EV/EBITDA 7.43
SYENS.BR Per share dataSYENS.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SYENS's earnings are expected to grow with 20.29% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.78%
EPS Next 3Y20.29%

1

5. Dividend

5.1 Amount

SYENS has a Yearly Dividend Yield of 1.56%.
SYENS's Dividend Yield is comparable with the industry average which is at 2.89.
SYENS's Dividend Yield is slightly below the S&P500 average, which is at 2.33.
Industry RankSector Rank
Dividend Yield 1.56%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
SYENS.BR Yearly Dividends per shareSYENS.BR Yearly Dividends per shareYearly Dividends per share 2024 0.5 1 1.5

5.3 Sustainability

The earnings of SYENS are negative and hence is the payout ratio. SYENS will probably not be able to sustain this dividend level.
DP-3400%
EPS Next 2Y18.78%
EPS Next 3Y20.29%
SYENS.BR Yearly Income VS Free CF VS DividendSYENS.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 500M -500M -1B

SYENSQO SA

EBR:SYENS (3/7/2025, 7:00:00 PM)

71.15

-1.37 (-1.89%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-27 2025-02-27
Earnings (Next)05-15 2025-05-15
Inst Owners27.72%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap7.47B
Analysts80.71
Price Target96.01 (34.94%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.56%
Yearly Dividend1.63
Dividend Growth(5Y)N/A
DP-3400%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.63%
Min Revenue beat(2)-1.4%
Max Revenue beat(2)2.66%
Revenue beat(4)1
Avg Revenue beat(4)-1.72%
Min Revenue beat(4)-4.25%
Max Revenue beat(4)2.66%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.1%
PT rev (3m)-0.71%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.38%
EPS NY rev (1m)-1.94%
EPS NY rev (3m)-6.62%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.43%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)-1.58%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 11.07
P/S 1.09
P/FCF 34.44
P/OCF 8.89
P/B 1.01
P/tB 2.38
EV/EBITDA 7.43
EPS(TTM)-0.07
EYN/A
EPS(NY)6.43
Fwd EY9.03%
FCF(TTM)2.07
FCFY2.9%
OCF(TTM)8.01
OCFY11.25%
SpS65.17
BVpS70.76
TBVpS29.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.04%
ROE -0.07%
ROCE 4.32%
ROIC 3.24%
ROICexc 3.48%
ROICexgc 6.24%
OM 6.59%
PM (TTM) N/A
GM 32.42%
FCFM 3.17%
ROA(3y)2.81%
ROA(5y)0.13%
ROE(3y)7.26%
ROE(5y)-1.97%
ROIC(3y)8.1%
ROIC(5y)7.41%
ROICexc(3y)8.68%
ROICexc(5y)7.84%
ROICexgc(3y)18.28%
ROICexgc(5y)18.48%
ROCE(3y)10.8%
ROCE(5y)9.88%
ROICexcg growth 3Y-25.5%
ROICexcg growth 5YN/A
ROICexc growth 3Y-16.23%
ROICexc growth 5YN/A
OM growth 3Y-11.73%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.24%
GM growth 5YN/A
F-Score5
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 9.75
Debt/EBITDA 1.54
Cap/Depr 85.25%
Cap/Sales 9.12%
Interest Coverage 250
Cash Conversion 71.09%
Profit Quality N/A
Current Ratio 1.71
Quick Ratio 1.05
Altman-Z 2.26
F-Score5
WACC6.83%
ROIC/WACC0.47
Cap/Depr(3y)98.43%
Cap/Depr(5y)76.05%
Cap/Sales(3y)9.47%
Cap/Sales(5y)8.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-102.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-26.54%
EPS Next Y20.04%
EPS Next 2Y18.78%
EPS Next 3Y20.29%
EPS Next 5Y9.44%
Revenue 1Y (TTM)-3.1%
Revenue growth 3Y4.31%
Revenue growth 5YN/A
Sales Q2Q%-49.24%
Revenue Next Year3.91%
Revenue Next 2Y4.78%
Revenue Next 3Y5.23%
Revenue Next 5Y4.25%
EBIT growth 1Y-47.48%
EBIT growth 3Y-7.93%
EBIT growth 5YN/A
EBIT Next Year70.07%
EBIT Next 3Y27.51%
EBIT Next 5Y15.27%
FCF growth 1Y-48.94%
FCF growth 3Y-7.48%
FCF growth 5YN/A
OCF growth 1Y-34.04%
OCF growth 3Y7.55%
OCF growth 5YN/A